Marrow raises $173M for siRNA drug to compete with one-time CRISPR therapy for sickle cell
When the FDA approved two gene therapies for sickle cell disease in December 2023, many drugmakers viewed it as the end of the story and …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Source link







